Targeted antibody therapies for malignant mesothelioma

Cancer Council Victoria

Doctor Peter Janes from Monash University and A/Professor Tom John from the Olivia Newton-John Cancer Research Institute will continue research into antibody therapies for malignant mesothelioma. They have developed antibodies against two cancer targets in malignant mesothelioma. Mesothelioma patient tissue will be screened to define eligible patient populations and mouse models will be used to developed effective therapy strategies.

The media release for this can be found on the Cancer Council Victoria website.

Date created